Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' reply.
Autori:
Chiappella A, Martelli M, Evangelista A, Vitolo U.
Rivista:
Lancet Oncol 2017; 18: e558. (IF 33.9)
Chiappella A, Martelli M, Evangelista A, Vitolo U.
Lancet Oncol 2017; 18: e558. (IF 33.9)